Organon & Co. (OGN)
Largest Insider Buys in Sector
OGN Stock Price History Chart
OGN Stock Performance
About Organon & Co.
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of …
Insider Activity of Organon & Co.
Over the last 12 months, insiders at Organon & Co. have bought $49,939 and sold $0 worth of Organon & Co. stock.
On average, over the past 5 years, insiders at Organon & Co. have bought $126,339 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Weaver Kirke (Gen. Counsel & Corp. Secy.) — $49,939.
The last purchase of 2,720 shares for transaction amount of $49,939 was made by Weaver Kirke (Gen. Counsel & Corp. Secy.) on 2024‑02‑22.
List of Insider Buy and Sell Transactions, Organon & Co.
| 2024-02-22 | Gen. Counsel & Corp. Secy. | 2,720 0.0011% | $18.36 | $49,939 | +0.08% | |||
| 2021-08-19 | director | 6,000 0.0023% | $33.79 | $202,740 | -0.30% |
Insider Historical Profitability
| Weaver Kirke | Gen. Counsel & Corp. Secy. | 15181 0.0059% | $14.93 | 1 | 0 | |
| Francisco Ma. Fatima | director | 3000 0.0012% | $14.93 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $630.38M | 13.04 | 33.53M | +0.02% | +$143,425.20 | 0.01 | |
| The Vanguard Group | $578.85M | 11.97 | 30.79M | +0.63% | +$3.62M | 0.01 | |
| Massachusetts Financial Services Co Ma | $190.87M | 3.95 | 10.15M | -0.57% | -$1.09M | 0.06 | |
| State Street | $174.75M | 3.61 | 9.3M | -1.56% | -$2.77M | 0.01 | |
| Citadel Advisors LLC | $116.13M | 2.4 | 6.18M | +46.72% | +$36.98M | 0.07 |